
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf Inc. has reported robust retail revenues of $255 million, reflecting a quarterly increase of 8.1% and an annual increase of 7.8%, with management expressing optimism about continued growth in the retail segment, particularly in Europe. The company has demonstrated a shift towards sustainable performance by achieving positive free cash flow (FCF) for four consecutive quarters, with an anticipated doubling of FCF to an estimated $205 million in 2025. Additionally, the company is targeting modest expansions in both gross and operating margins, further solidifying the positive outlook as these financial improvements are expected to bolster year-over-year earnings per share (EPS) growth in 2026.
Bears say
Diebold Nixdorf Inc faces a negative outlook due to several fundamental factors impacting its financial performance. Notably, the company's Banking segment has experienced a decline in gross margins, alongside a significant risk associated with technological missteps that could impair revenues and profitability. Additionally, external pressures such as increasing competition, tariff-related costs, and potential disruptions in supply chains further complicate the company’s ability to maintain operational stability and improve working capital.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares